Global Pontine Glioma Therapeutics Pipeline Review Report 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Pontine Glioma - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Pontine Glioma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pontine Glioma and special features on late-stage and discontinued projects.

The report enhances decision-making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Pontine Glioma Overview
  3. Therapeutics Development
  4. Pipeline Products for Pontine Glioma - Overview
  5. Pipeline Products for Pontine Glioma - Comparative Analysis
  6. Pontine Glioma - Therapeutics under Development by Companies
  7. Pontine Glioma - Therapeutics under Investigation by Universities/Institutes
  8. Pontine Glioma Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Pontine Glioma - Products under Development by Companies
  13. Pontine Glioma - Products under Investigation by Universities/Institutes
  14. Pontine Glioma - Companies Involved in Therapeutics Development
  • Arog Pharmaceuticals, Inc.
  • Burzynski Research Institute, Inc.
  • Loxo Oncology, Inc.
  • Medicenna Therapeutics, Inc.
  • Medivation, Inc.
  • Novogen Limited
  • Sanofi

For more information visit http://www.researchandmarkets.com/research/cpxt6h/pontine_glioma

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Brain Cancer Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Brain Cancer Drugs